Active GMP Recombinant Human LGALS9 protein

• Cat.No.: LGALS9-245HG
• Product Overview: GMP Recombinant Human LGALS9 protein(NP_002299.2)(323 aa), fused with His Tag at the C-terminal, was expressed in HEK293 cell in an animal component free process under cGMP guidelines.

Specification

• Species: Human
• Source: HEK293
• Protein Length: DNA sequence encoding Human Galectin-9(NCBI ReferenceSequence: NP_002299.2) was expressed with His tag at the C-terminal.
• Form: Freeze-dried powder contains Sterile PBS (pH 7.4) with 6% mannitol.
• Bio-activity: The immobilized protein detects its effect on the adhesion and migration of Jurkat cells (human acute T lymphocytic leukemia cells), and the ED50 of this effect is 1.1-4.2ug/mL.
• Molecular Mass: Recombinant Human LGALS9 protein contains 323 aa. It has a predicted MW of 37.4 kDa.
• Endotoxin: <0.01EU/ug
• Purity: >=95% by SDS-PAGE and HPLC
• Storage: The lyophilized preparation can be stored at 4°C for 24 months, and the dissolved liquid can be stored at -20°C for 6-12 months to avoid repeated freezing and thawing
• Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 ug/ul. Centrifuge the vial at 4°C before opening to recover the entire contents.

Gene Information

• Gene Name: LGALS9 lectin, galactoside-binding, soluble, 9 [ Homo sapiens ]
• Official Symbol: LGALS9
• Synonyms: LGALS9; Ecalectin
• Gene ID: 3965
• mRNA Refseq: NM_002308
• Protein Refseq: NP_002299
• MIM: 601879
• UniProt ID: O00182